These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 17092599)

  • 1. Multifunctional nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2006 Dec; 58(14):1532-55. PubMed ID: 17092599
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Multifunctional and stimuli-sensitive pharmaceutical nanocarriers.
    Torchilin V
    Eur J Pharm Biopharm; 2009 Mar; 71(3):431-44. PubMed ID: 18977297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent developments in lipid-based pharmaceutical nanocarriers.
    Musacchio T; Torchilin VP
    Front Biosci (Landmark Ed); 2011 Jan; 16(4):1388-412. PubMed ID: 21196238
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multifunctional nanomedicines: potentials and prospects.
    Agrawal U; Gupta M; Jadon RS; Sharma R; Vyas SP
    Drug Deliv Transl Res; 2013 Oct; 3(5):479-97. PubMed ID: 25788355
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanocarriers.
    Torchilin VP
    Pharm Res; 2007 Dec; 24(12):2333-4. PubMed ID: 17934800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tat peptide-mediated intracellular delivery of pharmaceutical nanocarriers.
    Torchilin VP
    Adv Drug Deliv Rev; 2008 Mar; 60(4-5):548-58. PubMed ID: 18053612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive and active drug targeting: drug delivery to tumors as an example.
    Torchilin VP
    Handb Exp Pharmacol; 2010; (197):3-53. PubMed ID: 20217525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A review of stimuli-responsive nanocarriers for drug and gene delivery.
    Ganta S; Devalapally H; Shahiwala A; Amiji M
    J Control Release; 2008 Mar; 126(3):187-204. PubMed ID: 18261822
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted polymeric micelles for delivery of poorly soluble drugs.
    Torchilin VP
    Cell Mol Life Sci; 2004 Oct; 61(19-20):2549-59. PubMed ID: 15526161
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell penetrating peptide-modified pharmaceutical nanocarriers for intracellular drug and gene delivery.
    Torchilin VP
    Biopolymers; 2008; 90(5):604-10. PubMed ID: 18381624
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current state, achievements, and future prospects of polymeric micelles as nanocarriers for drug and gene delivery.
    Nishiyama N; Kataoka K
    Pharmacol Ther; 2006 Dec; 112(3):630-48. PubMed ID: 16815554
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymeric vesicles: from drug carriers to nanoreactors and artificial organelles.
    Tanner P; Baumann P; Enea R; Onaca O; Palivan C; Meier W
    Acc Chem Res; 2011 Oct; 44(10):1039-49. PubMed ID: 21608994
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ocular drug delivery: nanomedicine applications.
    Vandervoort J; Ludwig A
    Nanomedicine (Lond); 2007 Feb; 2(1):11-21. PubMed ID: 17716187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The performance of nanocarriers for transmucosal drug delivery.
    Csaba N; Garcia-Fuentes M; Alonso MJ
    Expert Opin Drug Deliv; 2006 Jul; 3(4):463-78. PubMed ID: 16822222
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles.
    Mora L; Chumbimuni-Torres KY; Clawson C; Hernandez L; Zhang L; Wang J
    J Control Release; 2009 Nov; 140(1):69-73. PubMed ID: 19679152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in lipid nanodispersions for parenteral drug delivery and targeting.
    Constantinides PP; Chaubal MV; Shorr R
    Adv Drug Deliv Rev; 2008 Mar; 60(6):757-67. PubMed ID: 18096269
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravesical drug delivery: Challenges, current status, opportunities and novel strategies.
    GuhaSarkar S; Banerjee R
    J Control Release; 2010 Dec; 148(2):147-59. PubMed ID: 20831887
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active targeting of brain tumors using nanocarriers.
    Béduneau A; Saulnier P; Benoit JP
    Biomaterials; 2007 Nov; 28(33):4947-67. PubMed ID: 17716726
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted intracellular delivery of therapeutics: an overview.
    Rawat A; Vaidya B; Khatri K; Goyal AK; Gupta PN; Mahor S; Paliwal R; Rai S; Vyas SP
    Pharmazie; 2007 Sep; 62(9):643-58. PubMed ID: 17944316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.